[Home]   [Full version]  

Researchers uncover key trigger for potent cancer-fighting marine product

Jan 04 ,Medicine & Health



Full size image
An unexpected discovery in marine biomedical laboratories at Scripps Institution of Oceanography at UC San Diego has led to new, key information about the fundamental biological processes inside a marine organism that creates a natural product currently being tested to treat cancer in humans. The finding could lead to new applications of the natural product in treating human diseases.

A research team led by Bradley Moore, a professor with UCSD’s Scripps Oceanography Center for Marine Biotechnology and Biomedicine and Skaggs School of Pharmacy and Pharmaceutical Sciences, and postdoctoral researcher Alessandra Eustáquio, along with their colleagues at the Salk Institute for Biological Studies, discovered an enzyme called SalL inside Salinispora tropica, a promising marine bacterium identified in 1991 by Scripps researchers.


Full size image
As they describe in the most recent issue of Nature Chemical Biology, the researchers also identified a novel process—a “pathway”—for the way the marine bacterium incorporates a chlorine atom, the key ingredient for triggering its potent cancer-fighting natural product. Previously known methods for activating chlorine were processed through oxygen-based approaches. The new method, on the other hand, employs a substitution strategy that uses non-oxidized chlorine as it is found in nature, as with common table salt.

“This was a totally unexpected pathway,” said Moore. “There are well over 2,000 chlorinated natural products and this is the first example in which chlorine is assimilated by this kind of pathway,” said Moore.

The Salinispora derivative “salinosporamide A” is currently in phase I human clinical trials for the treatment of multiple myeloma and other cancers. A team led by Moore and Scripps’ Daniel Udwary solved the genome of S. tropica in June, an achievement that helped pave the way for the new discoveries.

Moore believes the discoveries provide a new “road map” for furthering S. tropica’s potential for drug development. Knowing the pathway of how the natural product is made biologically may give biotechnology and pharmaceutical scientists the ability to manipulate key molecules to engineer new versions of Salinispora-derived drugs. Genetic engineering may allow the development of second-generation compounds that can’t be found in nature.

“It’s possible that drug companies could manufacture this type of drug in greater quantities now that we know how nature makes it,” said Moore.

At this point it is unclear how pervasively SalL and its unique biological activation pathway exist in the ocean environment. Chlorine is a major component of seawater, and, according to Moore, a fundamental component of Salinispora’s disease-inhibiting abilities. Salinosporamide A, for example, is 500 times more potent than its chlorine-free analog salinosporamide B.

“The chlorine atom in salinosporamide A is key to the drug’s irreversible binding to its biological target and one of the reasons the drug is so effective against cancer,” said Moore.

According to Eustáquio, finding the enzyme and its new pathway also carries implications for understanding evolutionary developments, including clues for how and why related enzymes are activated in different ways.


Source: University of California - San Diego

Related stories:

2007 ozone hole 'smaller than usual'
The ozone hole over Antarctica has shrunk 30 percent as compared to last year's record size. According to measurements made by ESA’s Envisat satellite, this year’s ozone loss peaked at 27.7 million tonnes, compared to the 2006 record ozone loss of 40 million tonnes.
Study Finds Clock Ticking Slower On Ozone Hole Recovery
The Antarctic ozone hole's recovery is running late. According to a new NASA study, the full return of the protective ozone over the South Pole will take nearly 20 years longer than scientists previously expected.
Nasal spray using body's immune system provides hope of cure for common cold
Hopes of cure for common cold on the horizon
A nasal spray that mimics our own natural defense system may be the answer to beating the common cold, according to a report in the latest issue of the Society of Chemical Industry's (SCI) magazine, Chemistry & Industry, published today.
Purdue lab works to improve conditions at indoor swimming pools
Researchers at Purdue University have determined how certain airborne contaminants are created when chlorine reacts with sweat and urine in indoor swimming pools, a step toward learning how to reduce the formation of "volatile disinfection byproducts" that cause respiratory irritation.
Greener extraction of one of nature's whitest minerals
From medicine to make-up, plastics to paper - hardly a day goes by when we don't use titanium dioxide. Now researchers at the University of Leeds have developed a simpler, cheaper and greener method of extracting higher yields of one of this most useful and versatile of minerals.
Scientists enhance Mother Nature's carbon handling mechanism
Taking a page from Nature herself, a team of researchers developed a method to enhance removal of carbon dioxide from the atmosphere and place it in the Earth's oceans for storage.
Greenpeace opposes Italian gas terminal
Environmental activists want to block Italian plans to install a floating natural gas terminal in the middle of a whale and dolphin sanctuary.
NOAA scientists to search tropical skies
Scientists from NOAA’s Earth System Research Lab (ESRL) will be among 400 researchers in Costa Rica this summer to probe one of the most complex and least observed regions of Earth’s atmosphere during the rainy season. Based in San Jose, Costa Rica, the NASA-led field study will shed light on key processes related to climate change, the stratospheric ozone layer, and global chemistry. The study runs from July 2 through August 15.

News discussion:

Medicine & Health news

[Home]   [Full version]